C. Tom Kouroukis

Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12

Michael Crump, John Kuruvilla, Stephen Couban et al. · Journal of Clinical Oncology · 2014 · 454 citations · Full text

Flavopiridol in Untreated or Relapsed Mantle-Cell Lymphoma: Results of a Phase II Study of the National Cancer Institute of Canada Clinical Trials Group

C. Tom Kouroukis, Andrew Belch, Michael Crump et al. · Journal of Clinical Oncology · 2003 · 280 citations

Bortezomib Is Active in Patients With Untreated or Relapsed Waldenström's Macroglobulinemia: A Phase II Study of the National Cancer Institute of Canada Clinical Trials Group

Christine I. Chen, C. Tom Kouroukis, Darrell White et al. · Journal of Clinical Oncology · 2007 · 189 citations · Full text

A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia

Nancy M. Heddle, Richard J. Cook, Alan Tinmouth et al. · Blood · 2008 · 165 citations · Full text

A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150

Andrew R. Belch, C. Tom Kouroukis, Michael Crump et al. · Annals of Oncology · 2006 · 156 citations

Hematological Malignancy, National Cancer Institute, Lymphoid Neoplasia +11